Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.2.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 4,211,379 $ 4,992,145
Investments 14,128,120 21,253,866
Vendor receivable 173,499
Prepaid expenses and other current assets 683,359 527,380
Total current assets 19,022,858 26,946,890
Property and equipment, net 174,773 260,612
Intangible assets, net 18,389 19,309
Other assets 76,596 69,620
Total assets 19,292,616 27,296,431
Current liabilities:    
Accounts payable 257,317 371,993
Accrued liabilities 92,487 196,020
Accrued payroll and other compensation 196,695 754,314
Note payable, net of debt discount and offering costs of $0 and $8,723 as of September 30, 2022 and December 31, 2021, respectively 366,277
Total liabilities 546,499 1,688,604
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, Authorized 5,000,000 shares; No shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value, Authorized 12,000,000 shares; Issued and outstanding 2,906,926 shares as of September 30, 2022 and 2,877,985 as of December 31, 2021 2,907 2,878
Additional paid-in capital 111,855,921 110,339,011
Accumulated deficit (93,112,711) (84,734,062)
Total stockholders’ equity 18,746,117 25,607,827
Total liabilities and stockholders’ equity $ 19,292,616 $ 27,296,431